NCT02218008 A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study Status COMPLETED Phase PHASE3
NCT02209597 Clinical Study of Generic and Brand Bupropion in Depression Status COMPLETED Phase PHASE4
NCT02191124 The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial Status COMPLETED Phase PHASE4
NCT02188121 Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients Status COMPLETED Phase PHASE4
NCT02185131 Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Status COMPLETED Phase PHASE2
NCT02184221 Deep-brain Magnetic Stimulation (DMS) in the Treatment of Major Depressive Disorder Status COMPLETED Phase NA
NCT02181231 Buprenorphine Used With Treatment Resistant Depression in Older Adults Status COMPLETED Phase PHASE1/PHASE2
NCT02180607 Neuronal Responses to Social Feedback in Major Depressive Disorder Status COMPLETED Phase N/A
NCT02176408 Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression Status COMPLETED Phase NA
NCT02176291 Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine Status COMPLETED Phase PHASE2
NCT02176226 IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM) Status COMPLETED Phase NA
NCT02158546 A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study Status COMPLETED Phase PHASE3
NCT02158533 A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study Status COMPLETED Phase PHASE3
NCT02156622 CID 0911 - Adaptation of A Depression Treatment Intervention for HIV Patients in Cameroon Status COMPLETED Phase N/A